Evidence map›Paper›PMID 21810890›Full record

ArticleBrain : a journal of neurology2011

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Katya Rascovsky, John R Hodges, David Knopman, Mario F Mendez, Joel H Kramer, John Neuhaus, John C van Swieten, Harro Seelaar, Elise G P Dopper, Chiadi U Onyike and 36 more

5 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 2,685 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,685citing papers in PubMed, 4 pooled it
101.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06826157 naenrolling by invitationnot on this mapstarted 2021, after this paper: background citation

Assessing the Role of Advanced Electroencephalographic Data as Marker of Pathology and Prognosis in Primary Dementias

TypeinterventionalSponsorIRCCS San RaffaeleRan2021 to 2027Enrolled175ConditionsAlzheimer Disease, Lewy Body Dementia (LBD), Mild Alzheimer Disease, Frontotemporal Dementia (FTD)ArmsElectroencephalogram, 3 Tesla MRI, Apolipoprotein E genetic test
NCT07316413 narecruitingnot on this mapstarted 2025, after this paper: background citation

Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration

TypeinterventionalSponsorUniversità degli Studi di BresciaRan2025 to 2029Enrolled120ConditionsFTLD, FTD, bvFTD, PPAArmsTheta burst stimulation, Sham Theta burst stimulation
NCT07505784 narecruitingnot on this mapstarted 2026, after this paper: background citation

Cross-over Study to Evaluate the Safety, Tolerability, and Clinical Efficacy of Transcranial Alternating Current Stimulation (tACS) in Patients With Frontotemporal Dementia

TypeinterventionalSponsorIRCCS Centro San Giovanni di Dio FatebenefratelliRan2026 to 2027Enrolled30ConditionsTranscranial Alternating Current Stimulation, Frontotemporal Dementia (FTD)ArmsTranscranial Alternating Current Stimulation, Sham Transcranial Alternating Current Stimulation
NCT07531732 recruitingnot on this mapstarted 2026, after this paper: background citation

Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease

TypeobservationalSponsorAssistance Publique - Hôpitaux de ParisRan2026 to 2027Enrolled34ConditionsFrontotemporal Dementia, Behavioral Variant, Alzheimer DiseaseArmsComputer-based facial expression recognition task, Computerized affective task, UCLA Structured Insight Interview, Barber's Standardized Suggestibility Scale
NCT07731191 narecruitingnot on this mapstarted 2026, after this paper: background citation

Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)

TypeinterventionalSponsorIRCCS Centro San Giovanni di Dio FatebenefratelliRan2026 to 2026Enrolled240ConditionsMild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)ArmsDigital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of risk factors
3 · Its place in the literature

Who cites it

2,685 citing papers in PubMed, 4 syntheses or guidelines pooled it, 5,161 citations in OpenAlex.

  1. Pooled it
  2. The prevalence of frontotemporal dementia: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Social vulnerability as a key dimension of frailty in Alzheimer's disease and frontotemporal dementia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. A frontotemporal dementia-like phenotype in schizophrenia: links to striatal dopamine and iron accumulation.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Observational
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

2,625 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

46 authors at 20 institutions in 8 countries.

Katya RascovskyDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 West Gates, Philadelphia, PA 19104, USA. katyaras@mail.med.upenn.edu
John R Hodges
David Knopman
Mario F Mendez
Joel H Kramer
John Neuhaus
John C van Swieten
Harro Seelaar
Elise G P Dopper
Chiadi U Onyike
Argye E Hillis
Keith A Josephs
Bradley F Boeve
Andrew Kertesz
William W Seeley
Katherine P Rankin
Julene K Johnson
Maria-Luisa Gorno-Tempini
Howard Rosen
Caroline E Prioleau-Latham
Albert Lee
Christopher M Kipps
Patricia Lillo
Olivier Piguet
Jonathan D Rohrer
Martin N Rossor
Jason D Warren
Nick C Fox
Douglas Galasko
David P Salmon
Sandra E Black
Marsel Mesulam
Sandra Weintraub
Brad C Dickerson
Janine Diehl-Schmid
Florence Pasquier
Vincent Deramecourt
Florence Lebert
Yolande Pijnenburg
Tiffany W Chow
Facundo Manes
Jordan Grafman
Stefano F Cappa
Morris Freedman
Murray Grossman
Bruce L Miller
University Memory and Aging Center · USErasmus University Rotterdam · NLMayo Clinic in Arizona · USUniversité Lille Nord de France · FRUniversity College London · GBNeuroscience Research Australia · AUNorthwestern University · USUniversity of California, San Diego · USUniversity of California, San Francisco · USUniversity of Pennsylvania · USAmsterdam UMC Location VUmc · NLBaycrest Hospital · CAFavaloro University · ARHealth Sciences Centre · CAJohns Hopkins Medicine · USJohns Hopkins University · USKessler Foundation · USMassachusetts General Hospital · USUK Dementia Research Institute · GBUniversity of California, Los Angeles · US

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PANKRATZ, V. SHANE · 1999 to 2018
$36.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
The Frontotemporal Lobar Degeneration Neuroimaging InitiativeR01AG032306 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSEN, HOWARD J · 2009 to 2013
$10.0M
Neural Basis of Generalized QuantifiersR01NS044266 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GROSSMAN, MURRAY · 2004 to 2014
$6.8M
TDP-43 Proteinopathies in ALS-DementiaP01AG032953 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2010 to 2014
$5.8M
CONCEPTUAL PROCESSING IN ALZHEIMERS DISEASER01AG015116 · NIA · UNIVERSITY OF PENNSYLVANIA · PI GROSSMAN, MURRAY · 1998 to 2010
$4.3M
Multidisciplinary Study of Social Behavior and Emotion in Frontotemporal DementiaR01AG034499 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MENDEZ, MARIO F. · 2009 to 2013
$1.9M
CIHR 13129Medical Research Council G0601846Medical Research Council G0801306Medical Research Council G9724461NCRR NIH HHS UL1 RR025741NIA NIH HHS P01 AG017586NIA NIH HHS P01 AG019724NIA NIH HHS P01-AG019724NIA NIH HHS P01 AG032953NIA NIH HHS P01-AG17586NIA NIH HHS P01-AG32953NIA NIH HHS P50-AG016574NIA NIH HHS P50 AG023501NIA NIH HHS P50-AG023501NIA NIH HHS R01 AG015116NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG034499NIA NIH HHS R01-AG034499-02NIA NIH HHS R01-AG15116NINDS NIH HHS R01 NS044266NINDS NIH HHS R01-NS44266Wellcome Trust 091673
6 · The paper itself

Abstract

Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). 'Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. Cases with predominant primary progressive aphasia or extra-pyramidal syndromes were excluded. In these autopsy-confirmed cases, an experienced neurologist or psychiatrist ascertained clinical features necessary for making a diagnosis according to previous and proposed criteria at presentation. Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. In contrast, 72 cases (53%) met previously established criteria for the syndrome (P < 0.001 for comparison with 'possible' and 'probable' criteria). Patients who failed to meet revised criteria were significantly older and most had atypical presentations with marked memory impairment. In conclusion, the revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotemporal lobar degeneration. Greater sensitivity of the proposed criteria may reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations. Future studies will be needed to establish the reliability and specificity of these revised diagnostic guidelines.

Indexed as

Guidelines as TopicAgedBehaviorFemaleFrontotemporal DementiaHumansMaleMiddle AgedNeuropsychological TestsReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID21810890
PMCPMC3170532
OpenAlexW2128030851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.